MERK Merck Tbk

25 Oct 2021 20:16 (1 hari 11 jam lalu) - (Reuters) - U.S. drugmaker Merck & Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults. Under the procedure, also known as a "rolling review", the European Medicines Agency (EMA) would assess data as soon as it becomes available, instead of waiting for a formal application when all required information has been gathered. While vaccines are the main weapons against COVID-19, Merck's experimental pill molnupiravir could be a game-changer after studies showed it could halve the chances of dying or being hospitalised for those most at risk of contracti ...

25 Oct 2021 19:15 (1 hari 12 jam lalu) - Pemerintah telah melobi farmasi raksasa asal Amerika Serikat, Merck (MSD) untuk mendapatkan Molnupiravir. Menteri Kesehatan Budi Gunadi Sadikin mengatakan, Indonesia akan menerima antivirus Covid-19 tersebut pada akhir tahun ini. Hal ini disampaikan setelah Budi mengunjungi Merck di Amerika Serikat bersama Menteri Koordinator Bidang Kemaritiman dan Investasi Luhut Binsar Panjaitan. Dengan demikian, Indonesia akan memiliki cadangan stok antivirus guna menghadapi potensi Covid-19 gelombang ketiga. "Kami sudah sampai ke tahap finalisasi dari agreement agar Indonesia bisa mengadakan tablet Molnupiravir diusahakan akhir tahun ini," kata Budi dal ...

20 Oct 2021 23:45 (6 hari lalu) - By Dhirendra Tripathi Investing.com – Stocks of Merck (NYSE: MRK) and Pfizer (NYSE: PFE) rose over 2% each Wednesday as Britain contracted supplies of their yet-to-be-approved Covid-19 antivirals. "We may soon have a new defense in our arsenal with two new antiviral drugs that we have secured," Health Minister Sajid Javid said in a statement. Britain said it had secured 480,000 courses of Merck's molnupiravir, an antiviral pill which can be used in non-hospitalized patients. The company is yet to apply with drug regulators for approval to the medicine. The country has also secured 250,000 courses of Pfizer’s PF- 07321332 / ritonavir antiv ...

20 Oct 2021 23:05 (6 hari lalu) - LONDON (Reuters) - Britain said on Wednesday it had secured deals for two COVID-19 antivirals, one developed by Merck and the other by Pfizer (NYSE: PFE), which it said could be used to treat patients by the end of the year if regulatory approval is granted. Prime Minister Boris Johnson has removed almost all COVID-19 restrictions and is relying on COVID-19 vaccines and treatments to try and withstand winter pressures on hospitals given high case numbers of more than 40,000 new infections a day. "We may soon have a new defence in our arsenal with two new antiviral drugs that we have secured," health minister Sajid Javid said in a statement. ...

20 Oct 2021 13:18 (6 hari lalu) - (Reuters) - The Gates Foundation will allocate up to $120 million to help lower-income countries get an experimental COVID-19 drug being developed by U.S. drugmaker Merck & Co Inc in the battle against coronavirus, it said on Wednesday. The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for the disease if it wins regulatory approval, the foundation said in a statement. "Today's commitment will ensure that more people in more countries get access to the promising drug molnupiravir, but it's not the end of the story - we need other donors, including foundations and gove ...

19 Oct 2021 19:34 (7 hari lalu) - By Geoffrey Smith Investing.com -- Stocks in focus in premarket trading on Tuesday, 19th October. Please refresh for updates. - Procter & Gamble (NYSE: PG) stock fell 1.8% after the consumer products giant raised its estimate for how much higher input and transportation costs will take off its net profit this year. The company still upheld its annual profit forecast, saying it would raise prices for more of its staples. - Johnson & Johnson (NYSE: JNJ) stock rose 0.2% after it revised its full-year profit forecast marginally higher. It also repeated its target for sales of its Covid-19 vaccine, which are likely to be supported into next year ...

19 Oct 2021 18:49 (7 hari lalu) - (Reuters) -Atea Pharmaceuticals Inc's experimental COVID-19 antiviral pill, being developed with Roche, failed to help patients with mild and moderate COVID-19 in a small study of mostly low-risk patients, sending the U.S. drugmaker's shares plunging more than 70% on Tuesday. As a result, the company said it will not provide data from a larger late-stage study as planned this quarter and instead is considering modifying that trial with a possible data read-out delayed until the second half of 2022. The news puts Atea and Roche far behind U.S.-based Merck & Co Inc in the race to a pill to treat COVID-19. Merck applied for U.S. emergency use ...

19 Oct 2021 13:54 (7 hari lalu) - Menteri Koordinator Bidang Kemaritiman dan Investasi Luhut Binsar Pandjaitan bertemu dengan Penasihat Keamanan Nasional Amerika Serikat Jake Sullivan pada Senin (18/10). Juru bicara Gedung Putih Emily Horne mengatakan keduanya membicarakan sejumlah isu penting, termasuk soal pentingnya hubungan bilateral kedua negara. Sullivan juga menegaskan komitmennya untuk ikut terlibat di kancah perpolitikan Asia Tenggara sekaligus mempromosikan keterbukaan di kawasan Indo Pasifik. “Mereka juga berdiskusi mengenai perubahan iklim, situasi di Myanmar, dan isu lainnya,” ujar Horne dalam pernyataan resmi, Selasa (19/10). Horne menegaskan Amerika Serikat ...

19 Oct 2021 13:17 (7 hari lalu) - By Francesco Guarascio BRUSSELS (Reuters) - A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course, a draft document seen by Reuters says. Merck & Co's experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed. The document, which outlines the goals of the Access to COVID-19 Tools Accelerator (ACT-A) until September next year, says that the programme wants to deliver about 1 billion COVID-19 tests to poorer na ...

18 Oct 2021 20:39 (8 hari lalu) - Pemerintah terus membidik obat untuk menjaga pasokan bagi pasien Covid-19. Bahkan Menteri Koordinator Bidang Kemaritiman Luhut Binsar Pandjaitan dan Menteri Kesehatan Budi Gunadi Sadikin saat ini sedang berada di Amerika Serikat untuk menjajaki kerja sama pengembangan obat corona. Salah satu yang dibidik mereka adalah Molnupiravir yang diproduksi Merck & Co.”Saya bersama Menkes berada di AS untuk bertemu Merck mengenai Molnupiravir,” kata Luhut dalam konferensi pers virtual, Senin (18/10). Selain itu Luhut dan Budi juga membidik AT-527 yang diproduksi Roche serta Proxalutamide bikinan Kintor asal Cina. Meski demikian pemerintah ingin para p ...